Mirae Asset Global ETFs Holdings’s Assembly Biosciences ASMB Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$124K	Buy	+4,519	New	+$123K	﹤0.01%	2711

Other funds holding ASMB

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ASMB Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings opened a new position in Assembly Biosciences (ASMB) in Q2 2026: 4,519 shares worth $124K. The stake represents ﹤0.01% of the portfolio and ranks #2711 among its holdings.

93 funds tracked by Wall St. Rank hold ASMB as of Q2 2026.

Mirae Asset Global ETFs Holdings held 4,519 shares of Assembly Biosciences worth $124K as of Q2 2026.
Assembly Biosciences was a new Mirae Asset Global ETFs Holdings position in Q2 2026.
Assembly Biosciences made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2711 holding.
93 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.